Common questions about our mission, our work, and how to get involved.
We're a nonprofit dedicated to curing genetic disease. We build the benchmarks, research, and public understanding that gene editing needs to reach the people waiting on it, through three pillars: the CALI Competition, our mitochondrial gene therapy research lab, and State of the Genome, our public science communication effort.
CALI (Critical Assessment of Large Cargo Insertion) is a biennial, blind, unbiased benchmark competition for gene editing tools, modeled on how CASP transformed protein folding and led to breakthroughs like AlphaFold. It lets academia and industry compete, compare, and learn on equal footing.
BaseRead is our gene annotation tool. It takes raw sequencing data and guides it through variant detection and gene-level annotation, built on curated clinical databases like ClinVar and gnomAD. Read more on the BaseRead page.
Yes. [Add EIN / 501(c)(3) status details here once finalized.]
We're always glad to hear from potential partners and funders. Your support directly funds work like the inaugural CALI competition. Reach out via the contact section on the homepage.
We're building the team: researchers, engineers, and communicators who want to help build the benchmark gene editing has never had. Get in touch through the homepage contact section.
State of the Genome is our newsletter, podcast, and forum for public discourse on gene editing, AI in biology, and what it means for humanity. [Add subscribe link once live.]
See the Team page for our founder's background and the path that led to Genoma Institute.